MD223Y - Metoda de revaccinare a copiilor impotriva hepatitei virale B - Google Patents

Metoda de revaccinare a copiilor impotriva hepatitei virale B Download PDF

Info

Publication number
MD223Y
MD223Y MDS20100040A MDS20100040A MD223Y MD 223 Y MD223 Y MD 223Y MD S20100040 A MDS20100040 A MD S20100040A MD S20100040 A MDS20100040 A MD S20100040A MD 223 Y MD223 Y MD 223Y
Authority
MD
Moldova
Prior art keywords
viral hepatitis
revaccination
against viral
hbs
children against
Prior art date
Application number
MDS20100040A
Other languages
English (en)
Inventor
Angela Vranceanu-Benes
Constantin Spanu
Petru IAROVOI
Victor Pantea
Original Assignee
Centrul National Stiintifico-Practic De Medicina Preventiva Al Ministerului Sanatatii Al Republicii Moldova
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centrul National Stiintifico-Practic De Medicina Preventiva Al Ministerului Sanatatii Al Republicii Moldova filed Critical Centrul National Stiintifico-Practic De Medicina Preventiva Al Ministerului Sanatatii Al Republicii Moldova
Priority to MDS20100040A priority Critical patent/MD223Z/ro
Publication of MD223Y publication Critical patent/MD223Y/ro
Publication of MD223Z publication Critical patent/MD223Z/ro

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Inventia se refera la medicina, in special la boliile infectioase si poate fi utilizata pentru profilaxia hepatitei virale B. Conform inventiei, metoda de revaccinare a copiilor impotriva hepatitei virale B consta in aceea ca incepand cu varsta de un an, se determina anual nivelul de anticorpi anti-HBs si, in cazul in care nivelul anti-HBs este de la 10 pana la 150 mUI/ml, se administreaza o doza booster de vaccin impotriva hepatitei virale B, iar in cazul in care nivelul anti-HBs este mai mic de 10 mUI/ml, se administreaza un curs repetat din trei sau patru doze de vaccin impotriva hepatitei virale B.
MDS20100040A 2010-03-05 2010-03-05 Metodă de revaccinare a copiilor împotriva hepatitei virale B MD223Z (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDS20100040A MD223Z (ro) 2010-03-05 2010-03-05 Metodă de revaccinare a copiilor împotriva hepatitei virale B

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDS20100040A MD223Z (ro) 2010-03-05 2010-03-05 Metodă de revaccinare a copiilor împotriva hepatitei virale B

Publications (2)

Publication Number Publication Date
MD223Y true MD223Y (ro) 2010-06-30
MD223Z MD223Z (ro) 2011-02-28

Family

ID=45815075

Family Applications (1)

Application Number Title Priority Date Filing Date
MDS20100040A MD223Z (ro) 2010-03-05 2010-03-05 Metodă de revaccinare a copiilor împotriva hepatitei virale B

Country Status (1)

Country Link
MD (1) MD223Z (ro)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD975Z (ro) * 2015-01-28 2016-07-31 Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова Metodă de determinare a markerilor hepatitei virale B în sângele donatorului

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD3121G2 (ro) * 2005-09-15 2007-03-31 Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова Metodă de profilaxie a hepatitei virale B
  • 2010

Also Published As

Publication number Publication date
MD223Z (ro) 2011-02-28

Similar Documents

Publication Publication Date Title
CY1122291T1 (el) Αναστολeις ιικου αναδιπλασιασμου
CY1117819T1 (el) Ανοσοποιηση μεγαλων θηλαστικων με χαμηλες δοσεις rna
PH12018550201A1 (en) Hepatitis b antiviral agents
NI201800052A (es) Anticuerpos que neutraliza el virus respiratorio sincitial humano
PH12018550148A1 (en) Hepatitis b antiviral agents
PH12013501683A1 (en) Yeast-based therapeutic for chronic hepatitis b infection
JO3204B1 (ar) 4- أريل-n- فنيل-5،3،1- ترايازين-2- أمينات محتوية على مجموعة سلفوكسيمين
CY1119618T1 (el) Ενωσεις και συνθεσεις ως ρυθμιστικα μορια της tlr δραστηριοτητας
UA117246C2 (uk) Похідні сульфамоїлпіроламіду та їх застосування як медикаментів для лікування гепатиту в
MX342716B (es) Vacunas para su uso en la profilaxis y tratamiento de la enfermedad del virus de influenza.
MX2020011717A (es) Composiciones de vacuna que tienen estabilidad e inmunogenicidad mejoradas.
UA117518C2 (uk) 6-конденсовані гетероарилдигідропіримідини для лікування та профілактики зараження вірусом гепатиту b
UA116999C2 (uk) Виділене антитіло до гемаглютиніну та фармацевтична композиція, що його містить
FI3757126T3 (fi) Menetelmä nivelreuman hoitamiseksi il-17-antagonistien avulla
BR112018009009A2 (pt) terapia combinada de um inibidor de formação de capsídeo hbv e um interferon
MD20140058A2 (en) Compositions and methods for treating hepatitis C virus
EA201591586A1 (ru) Сульфамоил-ариламиды и их применение в качестве лекарственных препаратов для лечения гепатита b
MX2018005729A (es) Composiciones terapeuticas para tratamiento del virus de inmunodeficiencia humana.
EP2897640A4 (en) HEPATITIS B VIRUS CORE PROTEIN AND SURFACE ANTIBODY PROTEIN AND VACCINE THEREWITH
WO2014205199A3 (en) Compositions and methods for potentiating immune response, enhancing immunotherapy, and increasing vaccine potency
PH12015501076A1 (en) N-(pyridin-2-yl)pyrimidin-4-amine derivatives containing a sulfoximine group
EA201300132A1 (ru) Фармацевтическая композиция и методы лечения и профилактики заболеваний, вызванных вич или ассоциированных с вич
PH12018500201A1 (en) Enhanced immune response in porcine species
MD223Y (ro) Metoda de revaccinare a copiilor impotriva hepatitei virale B
MX2016000037A (es) Inhibidores de replicacion viral, su proceso de preparacion y sus usos terapeuticos.

Legal Events

Date Code Title Description
MK4Y Short term patent expired